I"<p>The <a href="https://www.nibib.nih.gov/" target="_blank" rel="noopener">National Institute of Biomedical Imaging and Bioengineering</a> (NIBIB) of the National Institutes of Health supports and encourages the development of new diagnostic technologies important for global health. Through this Challenge, NIBIB will offer $1,000,000 in prizes to reward and spur the development of platform concepts and prototypes of non-invasive, multiplexed diagnostic technologies for sickle cell disease, malaria, and anemia, diseases with high global and public health impact. The <a href="https://www.gatesfoundation.org/" target="_blank" rel="noopener">Bill &amp; Melinda Gates Foundation</a> shares a commitment to global health and is cooperating with NIBIB to consider additional support for the Challenge winners and honorable mentions. The Gates Foundation, separately, will review the Challenge winners and honorable mentions selected by NIBIB for potential follow-on funding of up to $500,000 and in-kind support that can transform design concepts into products for global health on an accelerated timeframe.</p>
<p>Five components of NIH have partnered with NIBIB to contribute to the $1,000,000 prize purse and will participate in selection of winners and honorable mentions:&nbsp; NIH Office of the Director; <a href="https://www.niaid.nih.gov/" target="_blank" rel="noopener">National Institute of Allergy and Infectious Disease</a>; <a href="https://www.nhlbi.nih.gov/" target="_blank" rel="noopener">National Heart, Lung and Blood Institute</a>; <a href="https://www.niddk.nih.gov/" target="_blank" rel="noopener">National Institute of Diabetes and Digestive and Kidney Diseases</a>; and the <a href="https://www.fic.nih.gov/Pages/Default.aspx" target="_blank" rel="noopener">Fogarty International Center</a>.</p>
<h4>Key Dates</h4>
<ul> <li>Register your intent:&nbsp; May 2, 2020</li> <li>Submissions open:&nbsp; March 2 - June 2, 2020</li> <li>Judging Start/End:&nbsp; June/July 2020</li> <li>NIBIB winners announced:&nbsp; August 2020</li> </ul>
:ET